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1Outcome document of the thirtieth special session of the 
General Assembly, entitled “Our joint commitment to effectively 
addressing and countering the world drug problem”1
 We, Heads of State and Government, ministers and representatives of Member 
States, are assembled at United Nations Headquarters from 19 to 21 April 2016 for the 
thirtieth special session of the General Assembly, convened in accordance with 
Assembly resolution 67/193 of 20 December 2012, to review the progress in the imple-
mentation of the Political Declaration and Plan of Action on International Cooperation 
towards an Integrated and Balanced Strategy to Counter the World Drug Problem,2 
including an assessment of the achievements and challenges in countering the world 
drug problem, within the framework of the three international drug control conven-
tions and other relevant United Nations instruments;
 We reaffirm our commitment to the goals and objectives of the three international 
drug control conventions, including concern about the health and welfare of human-
kind as well as the individual and public health-related, social and safety problems 
resulting from the abuse of narcotic drugs and psychotropic substances, in particular 
among children and young people, and drug-related crime, and we reaffirm our deter-
mination to prevent and treat the abuse of such substances and prevent and counter 
their illicit cultivation, production, manufacturing and trafficking;
 We recognize that, while tangible progress has been achieved in some fields, the 
world drug problem continues to present challenges to the health, safety and well-
being of all humanity, and we resolve to reinforce our national and international efforts 
and further increase international cooperation to face those challenges;
 We reaffirm our determination to tackle the world drug problem and to actively 
promote a society free of drug abuse in order to help to ensure that all people can live 
in health, dignity and peace, with security and prosperity, and reaffirm our determina-
tion to address public health, safety and social problems resulting from drug abuse;
1 General Assembly resolution S-30-1, annex. Adopted on 19 April 2016.
2 See Official Records of the Economic and Social Council, 2009, Supplement No.  8 (E/2009/28), 
chap.  I, sect. C.
2 We note with concern that the availability of internationally controlled drugs for 
medical and scientific purposes, including for the relief of pain and suffering, remains 
low to non-existent in many countries of the world, and we highlight the need to 
enhance national efforts and international cooperation at all levels to address that 
situation by promoting measures to ensure their availability and accessibility for medi-
cal and scientific purposes, within the framework of national legal systems, while 
simultaneously preventing their diversion, abuse and trafficking, in order to fulfil the 
aims and objectives of the three international drug control conventions;
 We recognize that the world drug problem remains a common and shared respon-
sibility that should be addressed in a multilateral setting through effective and increased 
international cooperation and demands an integrated, multidisciplinary, mutually rein-
forcing, balanced, scientific evidence-based and comprehensive approach;
 We reaffirm our unwavering commitment to ensuring that all aspects of demand 
reduction and related measures, supply reduction and related measures, and inter-
national cooperation are addressed in full conformity with the purposes and principles 
of the Charter of the United Nations, international law and the Universal Declaration 
of Human Rights,3 with full respect for the sovereignty and territorial integrity of 
States, the principle of non-intervention in the internal affairs of States, all human 
rights, fundamental freedoms, the inherent dignity of all individuals and the principles 
of equal rights and mutual respect among States;
 We underscore that the Single Convention on Narcotic Drugs of 1961 as amended 
by the 1972 Protocol,4 the Convention on Psychotropic Substances of 1971,5 the United 
Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 19886 and other relevant international instruments constitute the corner-
stone of the international drug control system;
 We reaffirm our commitment to implementing effectively the provisions set out in 
the Political Declaration and Plan of Action, mindful of the targets and goals set 
therein, as well as to addressing the general challenges and priorities for action identi-
fied in the Joint Ministerial Statement adopted at the high-level review in March 2014;7
 
3 Resolution 217 A  (III). 
4 United Nations, Treaty Series, vol.  976, No.  14152. 
5 Ibid., vol.  1019, No.  14956. 
6 Ibid., vol.  1582, No.  27627. 
7 Joint Ministerial Statement of the 2014 high-level review by the Commission on Narcotic Drugs of 
the implementation by Member States of the Political Declaration and Plan of Action on International 
Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem (see Official 
Records of the Economic and Social Council, 2014, Supplement No. 8 (E/2014/28), chap.  I, sect. C).
3 We welcome the 2030 Agenda for Sustainable Development,8 and we note that 
efforts to achieve the Sustainable Development Goals and to effectively address the 
world drug problem are complementary and mutually reinforcing;
 We recognize, as part of a comprehensive, integrated and balanced approach to 
addressing and countering the world drug problem, that appropriate emphasis should 
be placed on individuals, families, communities and society as a whole, with a view to 
promoting and protecting the health, safety and well-being of all humanity;
 We recognize the importance of appropriately mainstreaming gender and age 
perspectives in drug-related policies and programmes;
 We recognize that there are persistent, new and evolving challenges that should be 
addressed in conformity with the three international drug control conventions, which 
allow for sufficient flexibility for States parties to design and implement national drug 
policies according to their priorities and needs, consistent with the principle of com-
mon and shared responsibility and applicable international law;
 We reaffirm the need to mobilize adequate resources to address and counter the 
world drug problem and call for enhancing assistance to developing countries, upon 
request, in effectively implementing the Political Declaration and Plan of Action and 
the operational recommendations contained in the present document;
 We recognize that transit States continue to face multifaceted challenges, and 
reaffirm the continuing need for cooperation and support, including the provision of 
technical assistance to, inter alia, enhance their capacities to effectively address and 
counter the world drug problem, in conformity with the 1988 Convention;
 We reaffirm the principal role of the Commission on Narcotic Drugs as the policy-
making body of the United Nations with prime responsibility for drug control matters, 
and our support and appreciation for the efforts of the United Nations, in particular 
those of the United Nations Office on Drugs and Crime as the leading entity in the 
United Nations system for addressing and countering the world drug problem, and 
further reaffirm the treaty-mandated roles of the International Narcotics Control Board 
and the World Health Organization;
 We recognize that successfully addressing and countering the world drug problem 
requires close cooperation and coordination among domestic authorities at all levels, 
particularly in the health, education, justice and law enforcement sectors, taking into 
account their respective areas of competence under national legislation;
 We welcome continued efforts to enhance coherence within the United Nations 
system at all levels;
8 Resolution 70/1. 
4 We recognize that civil society, as well as the scientific community and academia, 
plays an important role in addressing and countering the world drug problem, and note 
that affected populations and representatives of civil society entities, where appropri-
ate, should be enabled to play a participatory role in the formulation, implementation, 
and the providing of relevant scientific evidence in support of, as appropriate, the 
evaluation of drug control policies and programmes, and we recognize the importance 
of cooperation with the private sector in this regard;
 We express deep concern at the high price paid by society and by individuals and 
their families as a result of the world drug problem, and pay special tribute to those 
who have sacrificed their lives, in particular law enforcement and judicial personnel, 
and to the health-care and civil society personnel and volunteers who dedicate them-
selves to countering and addressing this phenomenon;
 We reaffirm the need to strengthen cooperation between the United Nations Office 
on Drugs and Crime and other United Nations entities, within their respective man-
dates, in their efforts to support Member States in the implementation of international 
drug control treaties in accordance with applicable human rights obligations and to 
promote protection of and respect for human rights and the dignity of all individuals in 
the context of drug programmes, strategies and policies;
 We reaffirm the need to address the key causes and consequences of the world 
drug problem, including those in the health, social, human rights, economic, justice, 
public security and law enforcement fields, in line with the principle of common and 
shared responsibility, and recognize the value of comprehensive and balanced policy 
interventions, including those in the field of promotion of sustainable and viable 
livelihoods;
 We reaffirm that targeted interventions that are based on the collection and analy-
sis of data, including age- and gender-related data, can be particularly effective in 
meeting the specific needs of drug-affected populations and communities;
 We reiterate our commitment to ending, by 2030, the epidemics of AIDS and 
tuberculosis, as well as to combating viral hepatitis and other communicable diseases, 
inter alia, among people who use drugs, including people who inject drugs.
Operational recommendations on demand reduction and related 
measures, including prevention and treatment, as well as other  
health-related issues
1. We reiterate our commitment to promoting the health, welfare and well-being of all 
individuals, families, communities and society as a whole, and facilitating healthy life-
styles through effective, comprehensive, scientific evidence-based demand reduction 
5initiatives at all levels, covering, in accordance with national legislation and the three 
international drug control conventions, prevention, early intervention, treatment, care, 
recovery, rehabilitation and social reintegration measures, as well as initiatives and 
measures aimed at minimizing the adverse public health and social consequences of drug 
abuse, and we recommend the following measures:
Prevention of drug abuse
 (a) Take effective and practical primary prevention measures that protect peo-
ple, in particular children and youth, from drug use initiation by providing them with 
accurate information about the risks of drug abuse, by promoting skills and opportuni-
ties to choose healthy lifestyles and develop supportive parenting and healthy social 
environments and by ensuring equal access to education and vocational training;
 (b) Also take effective and practical measures to prevent progression to severe 
drug use disorders through appropriately targeted early interventions for people at risk 
of such progression;
 (c) Increase the availability, coverage and quality of scientific evidence-based 
prevention measures and tools that target relevant age and risk groups in multiple 
settings, reaching youth in school as well as out of school, among others, through drug 
abuse prevention programmes and public awareness-raising campaigns, including by 
using the Internet, social media and other online platforms, develop and implement 
prevention curricula and early intervention programmes for use in the education 
system at all levels, as well as in vocational training, including in the workplace, and 
enhance the capacity of teachers and other relevant professionals to provide or recom-
mend counselling, prevention and care services;
 (d) Promote the well-being of society as a whole through the elaboration of 
effective scientific evidence-based prevention strategies centred on and tailored to the 
needs of individuals, families and communities as part of comprehensive and balanced 
national drug policies, on a non-discriminatory basis;
 (e) Involve, as appropriate, policymakers, parliamentarians, educators, civil 
society, the scientific community, academia, target populations, individuals in recov-
ery from substance use disorders and their peer groups, families and other codependent 
people, as well as the private sector, in the development of prevention programmes 
aimed at raising public awareness of the dangers and risks associated with drug abuse, 
and involve, inter alia, parents, care services providers, teachers, peer groups, health 
professionals, religious communities, community leaders, social workers, sports 
associations, media professionals and entertainment industries, as appropriate, in their 
implementation;
 (f) Consider enhancing cooperation between public health, education and law 
enforcement authorities when developing prevention initiatives;
6 (g) Develop and improve recreational facilities and provide access for children 
and youth to regular sports and cultural activities, with a view to promoting healthy 
lives and lifestyles, including through the recovery and improvement of public spaces, 
and promote the exchange of experiences and good practices in this field to further 
enhance effective preventive interventions;
 (h) Promote and improve the systematic collection of information and gather-
ing of evidence as well as the sharing, at the national and international levels, of 
reliable and comparable data on drug use and epidemiology, including on social, 
economic and other risk factors, and promote, as appropriate, through the Commission 
on Narcotic Drugs and the World Health Assembly, the use of internationally recog-
nized standards, such as the International Standards on Drug Use Prevention, and the 
exchange of best practices, to formulate effective drug use prevention strategies and 
programmes in cooperation with the United Nations Office on Drugs and Crime, the 
World Health Organization and other relevant United Nations entities;
Treatment of drug use disorders, rehabilitation, recovery and social reintegration; 
prevention, treatment and care of HIV/AIDS, viral hepatitis and other blood-borne 
infectious diseases
 (i) Recognize drug dependence as a complex, multifactorial health disorder 
characterized by a chronic and relapsing nature with social causes and consequences 
that can be prevented and treated through, inter alia, effective scientific evidence-based 
drug treatment, care and rehabilitation programmes, including community-based 
programmes, and strengthen capacity for aftercare for and the rehabilitation, recovery 
and social reintegration of individuals with substance use disorders, including, as 
appropriate, through assistance for effective reintegration into the labour market and 
other support services;
 (j) Encourage the voluntary participation of individuals with drug use disorders 
in treatment programmes, with informed consent, where consistent with national legisla-
tion, and develop and implement outreach programmes and campaigns, involving drug 
users in long-term recovery, where appropriate, to prevent social marginalization and 
promote non-stigmatizing attitudes, as well as to encourage drug users to seek treatment 
and care, and take measures to facilitate access to treatment and expand capacity;
 (k) Promote and strengthen regional and international cooperation in develop-
ing and implementing treatment-related initiatives, enhance technical assistance and 
capacity-building and ensure non-discriminatory access to a broad range of interven-
tions, including psychosocial, behavioural and medication-assisted treatment, as 
appropriate and in accordance with national legislation, as well as to rehabilitation, 
social reintegration and recovery-support programmes, including access to such 
services in prisons and after imprisonment, giving special attention to the specific 
needs of women, children and youth in this regard;
7 (l) Develop and strengthen, as appropriate, the capacity of health, social and 
law enforcement and other criminal justice authorities to cooperate, within their 
mandates, in the implementation of comprehensive, integrated and balanced responses 
to drug abuse and drug use disorders, at all levels of government;
 (m) Promote the inclusion in national drug policies, in accordance with national 
legislation and as appropriate, of elements for the prevention and treatment of drug 
overdose, in particular opioid overdose, including the use of opioid receptor antago-
nists such as naloxone to reduce drug-related mortality;
 (n) Promote cooperation with and technical assistance to the States most 
affected by the transit of drugs in developing and implementing comprehensive and 
integrated policies to address, where appropriate, the impact of illicit drug trafficking 
on increasing drug use in such States, including by reinforcing national programmes 
aimed at prevention, early intervention, treatment, care, rehabilitation and social 
reintegration;
 (o) Invite relevant national authorities to consider, in accordance with their 
national legislation and the three international drug control conventions, including in 
national prevention, treatment, care, recovery, rehabilitation and social reintegration 
measures and programmes, in the context of comprehensive and balanced drug demand 
reduction efforts, effective measures aimed at minimizing the adverse public health 
and social consequences of drug abuse, including appropriate medication-assisted 
therapy programmes, injecting equipment programmes, as well as antiretroviral ther-
apy and other relevant interventions that prevent the transmission of HIV, viral hepati-
tis and other blood-borne diseases associated with drug use, as well as consider 
ensuring access to such interventions, including in treatment and outreach services, 
prisons and other custodial settings, and promoting in that regard the use, as appropri-
ate, of the technical guide for countries to set targets for universal access to HIV pre-
vention, treatment and care for injecting drug users, issued by the World Health 
Organization, the United Nations Office on Drugs and Crime and the Joint United 
Nations Programme on HIV/AIDS;
 (p) Promote and implement the standards on the treatment of drug use disor-
ders developed by the United Nations Office on Drugs and Crime and the World Health 
Organization and other relevant international standards, as appropriate and in accord-
ance with national legislation and the international drug control conventions, and 
provide guidance, assistance and training to health professionals on their appropriate 
use, and consider developing standards and accreditation for services at the domestic 
level to ensure qualified and scientific evidence-based responses;
 (q) Intensify, as appropriate, the meaningful participation of and support and 
training for civil society organizations and entities involved in drug-related health 
and social treatment services, in accordance with national legislation and in the frame-
work of integrated and coordinated national drug policies, and encourage efforts by 
8civil society and the private sector to develop support networks for prevention and 
treatment, care, recovery, rehabilitation and social reintegration in a balanced and 
inclusive manner;
 (r) Encourage the United Nations Office on Drugs and Crime and the 
International Narcotics Control Board to strengthen cooperation with the World Health 
Organization and other competent United Nations entities, within their respective 
mandates, as part of a comprehensive, integrated and balanced approach to strengthen-
ing health and social welfare measures in addressing the world drug problem, includ-
ing through effective prevention, early intervention, treatment, care, recovery, 
rehabilitation and social reintegration, in cooperation, as appropriate, with civil society 
and the scientific community, and to keep the Commission on Narcotic Drugs appro-
priately updated.
Operational recommendations on ensuring the availability of and access 
to controlled substances exclusively for medical and scientific purposes, 
while preventing their diversion
2. We reiterate our strong commitment to improving access to controlled substances 
for medical and scientific purposes by appropriately addressing existing barriers in this 
regard, including those related to legislation, regulatory systems, health-care systems, 
affordability, the training of health-care professionals, education, awareness-raising, 
estimates, assessment and reporting, benchmarks for consumption of substances under 
control, and international cooperation and coordination, while concurrently preventing 
their diversion, abuse and trafficking, and we recommend the following measures:
 (a) Consider reviewing, within the framework of national legal systems, 
domestic legislation and regulatory and administrative mechanisms, as well as proce-
dures including domestic distribution channels, with the aim of simplifying and 
streamlining those processes and removing unduly restrictive regulations and impedi-
ments, where they exist, to ensure access to controlled substances for medical and 
scientific purposes, including for the relief of pain and suffering, as required by the 
three international drug control conventions and defined by national legislation, while 
preventing their diversion, abuse and trafficking, and encourage the exchange of infor-
mation, lessons learned and best practices in designing and implementing regulatory, 
financial, educational, administrative and other related measures;
 (b) Strengthen, as appropriate, the proper functioning of national control 
systems and domestic assessment mechanisms and programmes, in cooperation with 
the International Narcotics Control Board, the United Nations Office on Drugs and 
Crime, the World Health Organization and other relevant United Nations system agen-
cies, to identify, analyse and remove impediments to the availability and accessibility 
of controlled substances for medical and scientific purposes, within appropriate 
9control mechanisms, as required by the three international drug control conventions 
and taking into account the publication entitled “Ensuring Balance in National Policies 
on Controlled Substances: Guidance for Availability and Accessibility of Controlled 
Medicines” and, for that purpose, consider the provision of technical and financial 
assistance, upon request, to developing countries;
 (c) Expedite, in accordance with national legislation, the process of issuing 
import and export authorizations for controlled substances for medical and scientific 
purposes by using the above-mentioned guidance and the International Import and 
Export Authorization System of the International Narcotics Control Board;
 (d) Address, at the national and international levels, issues related to the afford-
ability of controlled substances for medical and scientific purposes, while ensuring 
their quality, safety and efficacy, including limited financial resources and problems in 
sourcing with regard to these substances, including in cooperation, as appropriate, 
with the private sector through, inter alia and where needed, expanding the national 
coverage of distribution networks to rural areas, addressing the link with government 
regulations, licences and taxation and allowing appropriately trained and qualified 
professionals to prescribe, dispense and administer controlled medicines based on 
their general professional licence, as well as, where appropriate, the manufacture of 
generic pharmaceutical preparations that are bioequivalent and cost-effective;
 (e) Take measures, in accordance with national legislation, to provide capacity-
building and training, including with the support of relevant United Nations entities 
such as the World Health Organization and the United Nations Office on Drugs and 
Crime, targeted at competent national authorities and health-care professionals, includ-
ing pharmacists, on adequate access to and use of controlled substances for medical 
and scientific purposes, including the relief of pain and suffering, consider the 
development and wider implementation of relevant clinical guidelines on the rational 
use of controlled medicines, and conduct appropriate awareness-raising campaigns 
under the coordination of relevant national health authorities and in cooperation with 
other relevant stakeholders;
 (f) Develop national supply management systems for controlled substances 
that comprise selection, quantification, procurement, storage, distribution and use, 
strengthen the capacity of competent national authorities to adequately estimate and 
assess the need for controlled substances and paying special attention to essential 
medicines, as defined by national legislation, taking due note of the Guide on 
Estimating Requirements for Substances under International Control,9 and enhance 
domestic data-collection mechanisms in order to present the International Narcotics 
Control Board with estimates on the consumption of drugs used for medical and scien-
tific purposes;
9 International Narcotics Control Board and World Health Organization (Vienna, 2012).
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 (g) Continue to regularly update the Model Lists of Essential Medicines of the 
World Health Organization, enhance collaboration among Member States and the treaty 
bodies with scheduling responsibilities, leading to informed and coordinated scheduling 
decisions by the Commission on Narcotic Drugs that take due account of all relevant 
aspects to ensure that the objectives of the conventions are met, and review national lists 
of controlled substances and national lists of essential medicines, as appropriate.
Operational recommendations on supply reduction and related measures; 
effective law enforcement; responses to drug-related crime; and 
countering money-laundering and promoting judicial cooperation
3. We reiterate our commitment to protecting the safety and assuring the security of 
individuals, societies and communities by intensifying our efforts to prevent and coun-
ter the illicit cultivation, production and manufacture of and trafficking in narcotic 
drugs and psychotropic substances, as well as drug-related crime and violence, 
through, inter alia, more effective drug-related crime prevention and law enforcement 
measures, as well as by addressing links with other forms of organized crime, includ-
ing money-laundering, corruption and other criminal activities, mindful of their social 
and economic causes and consequences, and we recommend the following measures:
Prevention of drug-related crime
 (a) Strengthen multidisciplinary measures at the international, regional, 
national, and local and community levels to prevent drug-related crime, violence, 
victimization and corruption and foster social development and inclusiveness, 
integrate such measures into overall law enforcement efforts and comprehensive 
policies and programmes, and promote a culture of lawfulness, as described in the 
Doha Declaration on Integrating Crime Prevention and Criminal Justice into the Wider 
United Nations Agenda to Address Social and Economic Challenges and to Promote 
the Rule of Law at the National and International Levels, and Public Participation;10
 (b) Promote comprehensive supply reduction efforts that include preventive 
measures addressing, inter alia, the criminal justice and socioeconomic-related factors 
that may facilitate, drive, enable and perpetuate organized crime and drug-related 
crime;
 (c) Promote data collection, research and the sharing of information, as well as 
the exchange of best practices on preventing and countering drug-related crime and on 
drug supply reduction measures and practices, in order to enhance the effectiveness of 
criminal justice responses, within the framework of applicable law;
10 Resolution 70/174, annex.
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Countering illicit traffic in narcotic drugs and psychotropic substances
 (d) Increase cooperation at all levels and enhance measures to prevent and sig-
nificantly and measurably reduce or eliminate the illicit cultivation of opium poppy, 
coca bush and cannabis plant used for the production of narcotic drugs and psycho-
tropic substances, including through eradication, within the framework of sustainable 
crop control strategies and measures;
 (e) Monitor current trends and drug trafficking routes and share experiences, 
best practices and lessons learned, in order to prevent and counter the misuse of inter-
national trade for illicit drug-related activities, and note the success achieved through 
United Nations Office on Drugs and Crime operational initiatives, including initiatives 
aimed at countering the exploitation of freight containers for drug trafficking and at 
preventing and countering the diversion of precursors for illicit use and illicit financial 
flows stemming from drug trafficking and related crimes, as well as other technical 
assistance activities;
 (f) Promote and strengthen the exchange of information and, as appropriate, 
drug-related criminal intelligence among law enforcement and border control 
agencies, including through the United Nations Office on Drugs and Crime multilat-
eral portals and regional information centres and networks, and promote joint investi-
gations and coordinate operations, in conformity with national legislation, and training 
programmes at all levels, in order to identify, disrupt and dismantle organized criminal 
groups operating transnationally that are involved in any activities related to the illicit 
production of and trafficking in narcotic drugs and psychotropic substances and the 
diversion of their precursors and related money-laundering;
 (g) Strengthen coordinated border management strategies, as well as the 
capacity of border control and law enforcement and prosecutorial agencies, including 
through technical assistance, upon request, including and where appropriate, the provi-
sion of equipment and technology, along with necessary training and maintenance 
support, in order to prevent, monitor and counter trafficking in drugs, trafficking in 
precursors and other drug-related crimes such as trafficking in firearms, illicit financial 
flows, smuggling of bulk cash and money-laundering;
 (h) Enhance the capacity of law enforcement and criminal justice agencies in 
forensic science in the context of drug investigations, including the quality and 
capacity of drug analysis laboratories to gather, preserve and present forensic evidence 
to effectively prosecute drug-related offences through considering, inter  alia, the 
provision of advanced detection equipment, scanners, testing kits, reference samples, 
forensic laboratories and training, as requested;
 (i) Strengthen regional, subregional and international cooperation in criminal 
matters, as appropriate, including judicial cooperation in the areas of, inter alia, extra-
dition, mutual legal assistance and transfer of proceedings, in accordance with the 
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international drug control conventions and other international legal instruments and 
national legislation, and strive to provide appropriate resources to national competent 
authorities, including through the provision of targeted technical assistance to request-
ing countries;
 (j) Maximize the effectiveness of law enforcement measures against organized 
criminal groups and individuals involved in drug-related crimes, including by placing 
appropriate focus within our respective jurisdictions on those responsible for illicit 
activities of a larger scale or more serious nature;
Addressing links with other forms of organized crime, including money-laundering, 
corruption and other criminal activities
 (k) Respond to the serious challenges posed by the increasing links between 
drug trafficking, corruption and other forms of organized crime, including trafficking 
in persons, trafficking in firearms, cybercrime and money-laundering, and, in some 
cases, terrorism, including money-laundering in connection with the financing of ter-
rorism, by using an integrated, multidisciplinary approach, such as through promoting 
and supporting reliable data collection, research and, as appropriate, intelligence- and 
analysis-sharing to ensure effective policymaking and interventions;
 (l) Encourage the use of existing subregional, regional and international coop-
eration mechanisms to combat all forms of drug-related crime, wherever committed, 
including, in some cases, violent crimes related to gangs, including by enhancing inter-
national cooperation to successfully counter and dismantle organized criminal groups, 
including those operating transnationally;
 (m) Strengthen national, regional and international measures and, as appropri-
ate, rules and regulations aimed at enhancing operational cooperation to prevent trans-
national organized criminal networks involved in illicit drug-related activities from 
trafficking and acquiring firearms, their parts and components and ammunition, explo-
sives and other related material;
 (n) Consider ratifying or acceding to relevant international legal instruments, 
including the United Nations Convention against Transnational Organized Crime and 
the Protocols thereto,11 the United Nations Convention against Corruption12 and the 
international conventions and protocols related to countering terrorism, and call upon 
States parties to take measures to more effectively implement those international legal 
instruments;
 (o) Continue to foster international cooperation by implementing the provi-
sions against money-laundering contained in all relevant international and multilateral 
11 United Nations, Treaty Series, vols. 2225, 2237, 2241 and 2326, No.  39574.
12 Ibid., vol.  2349, No.  42146. 
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instruments, such as the 1988 Convention, the Organized Crime Convention and the 
Convention against Corruption and, in accordance with national legislation, the 
Financial Action Task Force Recommendations on money-laundering;13
 (p) Strengthen and utilize existing and relevant regional, as appropriate, sub-
regional and international networks for the exchange of operational information to 
prevent and counter money-laundering, illicit financial flows and terrorist financing;
 (q) Develop and strengthen, as appropriate, mechanisms of domestic coordina-
tion and timely and efficient information-sharing between authorities involved in 
identifying and countering drug trafficking, diversion of precursors and related money-
laundering, integrate financial investigations more thoroughly into interdiction opera-
tions to identify individuals and companies involved in such activities, and encourage, 
in accordance with national legislation, cooperation with the private sector, including 
financial institutions, designated non-financial businesses and professions, as well as 
providers of money or value transfer services, to identify suspicious transactions, with 
a view to further investigating and disrupting the drug trafficking business model;
 (r) Enhance national, regional, subregional, interregional and international 
capacity to prevent and counter money-laundering and illicit financial flows stemming 
from drug trafficking and related crimes, including, as appropriate, through detection, 
investigation and prosecution of such activities, with a view to effectively addressing 
safe havens, and identify and mitigate money-laundering risks linked to new techno-
logies, as well as emerging money-laundering methods and techniques, by using, inter 
alia, existing United Nations Office on Drugs and Crime technical assistance tools;
 (s) Develop and strengthen bilateral, subregional and international mechanisms 
to share information among competent authorities and promote their cooperation to 
effectively and in a timely manner identify, trace, freeze, seize and confiscate assets 
and proceeds of drug-related crime and ensure their disposal, including sharing, in 
accordance with the 1988 Convention, as well as their return, in appropriate drug-
related corruption cases, in the framework of the Convention against Corruption, or, as 
appropriate, in cases of drug-related crimes involving transnational organized groups, 
consistent with the Organized Crime Convention; and encourage the timely sharing of 
operational information among relevant law enforcement and prosecutorial agencies 
and financial intelligence units;
 (t) Promote effective measures capable of addressing the links between drug-
related crimes and corruption, as well as obstruction of justice, including through the 
intimidation of justice officials, as a part of national anti-corruption and drug control 
strategies;
13 Financial Action Task Force, International Standards on Combating Money Laundering and the 
Financing of Terrorism and Proliferation (Paris, 2015).
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 (u) Improve the availability and quality of statistical information and analysis 
of illicit drug cultivation, production and manufacturing, drug trafficking, money-
laundering and illicit financial flows, including for appropriate reflection in reports of 
the United Nations Office on Drugs and Crime and the International Narcotics Control 
Board, in order to better measure and evaluate the impact of such crimes and to further 
enhance the effectiveness of criminal justice responses in that regard.
Operational recommendations on cross-cutting issues: drugs and human 
rights, youth, children, women and communities
4. We reiterate our commitment to respecting, protecting and promoting all human 
rights, fundamental freedoms and the inherent dignity of all individuals and the rule of 
law in the development and implementation of drug policies, and we recommend the 
following measures:
Drugs and human rights, youth, women, children, vulnerable members of society, and 
communities
 (a) Enhance the knowledge of policymakers and the capacity, as appropriate, of 
relevant national authorities on various aspects of the world drug problem in order to 
ensure that national drug policies, as part of a comprehensive, integrated and 
balanced approach, fully respect all human rights and fundamental freedoms and pro-
tect the health, safety and well-being of individuals, families, vulnerable members of 
society, communities and society as a whole, and to that end encourage cooperation 
with and among the United Nations Office on Drugs and Crime, the International 
Narcotics Control Board, the World Health Organization and other relevant United 
Nations entities, within their respective mandates, including those relevant to the 
above-mentioned issues, and relevant regional and international organizations, as well 
as with civil society and the private sector, as appropriate;
 (b) Ensure non-discriminatory access to health, care and social services in 
prevention, primary care and treatment programmes, including those offered to persons 
in prison or pretrial detention, which are to be on a level equal to those available in the 
community, and ensure that women, including detained women, have access to adequate 
health services and counselling, including those particularly needed during pregnancy;
 (c) Promote effective supervision of drug treatment and rehabilitation facilities 
by competent domestic authorities to ensure adequate quality of drug treatment and 
rehabilitation services and to prevent any possible acts of cruel, inhuman or degrading 
treatment or punishment, in accordance with domestic legislation and applicable inter-
national law;
 (d) Continue to identify and address protective and risk factors, as well as the 
conditions that continue to make women and girls vulnerable to exploitation and 
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participation in drug trafficking, including as couriers, with a view to preventing their 
involvement in drug-related crime;
 (e) Promote, in accordance with domestic legislation, effective coordination 
among the justice, education and law enforcement sectors and social services to ensure 
that the specific needs, including mental and physical needs, of underage drug offend-
ers and children affected by drug-related crime are appropriately considered, including 
in criminal justice proceedings where required, including by providing those in need 
with drug treatment and related support services;
 (f) Implement age-appropriate practical measures, tailored to the specific needs 
of children, youth and other vulnerable members of society, in the legislative, admin-
istrative, social, economic, cultural and educational sectors, including measures to 
provide them with opportunities for healthy and self-sustained lives, in order to pre-
vent their abuse of narcotic drugs and psychotropic substances, and address their 
involvement, use and exploitation in the illicit cultivation of crops, production and 
manufacturing of and trafficking in narcotic drugs, psychotropic substances and other 
forms of drug-related crime, including urban crime, youth and gang-related violence 
and crime, fulfilling the obligations as States parties to the Convention on the Rights 
of the Child14 and taking into account the United Nations Guidelines for the Prevention 
of Juvenile Delinquency (the Riyadh Guidelines);15
 (g) Mainstream a gender perspective into and ensure the involvement of women 
in all stages of the development, implementation, monitoring and evaluation of drug poli-
cies and programmes, develop and disseminate gender-sensitive and age-appropriate 
measures that take into account the specific needs and circumstances faced by women 
and girls with regard to the world drug problem and, as States parties, implement the 
Convention on the Elimination of All Forms of Discrimination against Women;16
 (h) Consider, on a voluntary basis, when furnishing information to the 
Commission on Narcotic Drugs pursuant to the three international drug control con-
ventions and relevant Commission resolutions, the inclusion of information concern-
ing, inter alia, the promotion of human rights and the health, safety and welfare of all 
individuals, communities and society in the context of their domestic implementation 
of these conventions, including recent developments, best practices and challenges;
 (i) Ensure that measures to prevent the illicit cultivation of and to eradicate 
plants containing narcotic and psychotropic substances respect fundamental human 
rights, take due account of traditional licit uses, where there is historical evidence of 
such use, and of the protection of the environment, in accordance with the three 
14 United Nations, Treaty Series, vol. 1577, No. 27531.
15 Resolution 45/112, annex.
16 United Nations, Treaty Series, vol.  1249, No.  20378.
16
international drug control conventions, and also take into account, as appropriate and 
in accordance with national legislation, the United Nations Declaration on the Rights 
of Indigenous Peoples;17
Proportionate and effective policies and responses, as well as legal guarantees and 
safeguards pertaining to criminal justice proceedings and the justice sector
 (j) Encourage the development, adoption and implementation, with due regard 
for national, constitutional, legal and administrative systems, of alternative or additional 
measures with regard to conviction or punishment in cases of an appropriate nature, in 
accordance with the three international drug control conventions and taking into 
account, as appropriate, relevant United Nations standards and rules, such as the United 
Nations Standard Minimum Rules for Noncustodial Measures (the Tokyo Rules);18
 (k) Consider sharing, through the Commission on Narcotic Drugs, information, 
lessons learned, experiences and best practices on the design, implementation and 
results of national criminal justice policies, including, as appropriate, domestic prac-
tices on proportional sentencing, related to the implementation of the three inter-
national drug control conventions, including article 3 of the 1988 Convention;
 (l) Promote proportionate national sentencing policies, practices and guidelines 
for drug-related offences whereby the severity of penalties is proportionate to the gravity 
of offences and whereby both mitigating and aggravating factors are taken into account, 
including the circumstances enumerated in article 3 of the 1988 Convention and other 
relevant and applicable international law, and in accordance with national legislation;
 (m) Enhance access to treatment of drug use disorders for those incarcerated 
and promote effective oversight and encourage, as appropriate, self-assessments of 
confinement facilities, taking into consideration the United Nations standards and 
norms on crime prevention and criminal justice, including the United Nations Standard 
Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules),19 imple-
ment, where appropriate, measures aimed at addressing and eliminating prison over-
crowding and violence, and provide capacity-building to relevant national authorities;
 (n) Encourage the taking into account of the specific needs and possible 
multiple vulnerabilities of women drug offenders when imprisoned, in line with the 
United Nations Rules for the Treatment of Women Prisoners and Non-custodial 
Measures for Women Offenders (the Bangkok Rules);20
17 Resolution 61/295, annex.
18 Resolution 45/110, annex.
19 Resolution 70/175, annex.
20 Resolution 65/229, annex.
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 (o) Promote and implement effective criminal justice responses to drug-related 
crimes to bring perpetrators to justice that ensure legal guarantees and due process 
safeguards pertaining to criminal justice proceedings, including practical measures to 
uphold the prohibition of arbitrary arrest and detention and of torture and other cruel, 
inhuman or degrading treatment or punishment and to eliminate impunity, in accord-
ance with relevant and applicable international law and taking into account United 
Nations standards and norms on crime prevention and criminal justice, and ensure 
timely access to legal aid and the right to a fair trial.
Operational recommendations on cross-cutting issues in addressing and 
countering the world drug problem: evolving reality, trends and existing 
circumstances, emerging and persistent challenges and threats, including 
new psychoactive substances, in conformity with the three international 
drug control conventions and other relevant international instruments
5. We reiterate our commitment to strengthening our efforts in addressing and coun-
tering emerging and persistent challenges and threats of all aspects of the world drug 
problem, and note the need to effectively respond to the evolving reality, trends and 
existing circumstances through comprehensive, integrated and balanced drug control 
policies and programmes that take into account their transnational implications and 
that are in conformity with the three international drug control conventions and other 
relevant international instruments, and to strengthen our international, regional and 
subregional cooperation, and we recommend the following:
Addressing new psychoactive substances, amphetamine-type stimulants,  
including methamphetamine, the diversion of precursors and pre-precursors and the 
non-medical use and misuse of pharmaceuticals containing narcotic drugs and 
psychotropic substances
 We resolve to strengthen national and international action to address the emerging 
challenge of new psychoactive substances, including their adverse health conse-
quences, and the evolving threat of amphetamine-type stimulants, including metham-
phetamine, and underscore the importance of enhancing information-sharing and early 
warning networks, developing appropriate national legislative, prevention and treat-
ment models and supporting scientific evidence-based review and scheduling of the 
most prevalent, persistent and harmful substances, we note the importance of prevent-
ing the diversion and misuse of pharmaceuticals containing narcotic drugs and psycho-
tropic substances and precursors while ensuring their availability for legitimate 
purposes, and we recommend the following measures:
 (a) Encourage the development and implementation of, as appropriate and in 
accordance with national legislation, comprehensive measures and programmes, as 
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outlined in paragraph 1 of the present document, adapt those measures to the risks and 
challenges posed by the use of new psychoactive substances and amphetamine-type 
stimulants, including methamphetamine, and the non-medical use and misuse of 
pharmaceuticals containing narcotic drugs and psychotropic substances, and actively 
share information on best practices and lessons learned with regard to national health-
related experiences;
 (b) Enhance the capacity of law enforcement agencies to detect and identify 
new psychoactive substances and amphetamine-type stimulants, including metham-
phetamine, and promote cross-border cooperation and information-sharing to prevent 
their abuse and diversion, including through the use of existing International Narcotics 
Control Board and United Nations Office on Drugs and Crime tools and projects;
 (c) Establish and strengthen partnerships and information exchange with 
industries, in particular with chemical and pharmaceutical industries and other relevant 
private sector entities, and encourage the use of the Guidelines for a Voluntary Code 
of Practice for the Chemical Industry, issued by the International Narcotics Control 
Board, and the Board’s model memorandum of understanding between Governments 
and private sector partners, as and where appropriate, bearing in mind the important 
role these industries can play in addressing and countering the world drug problem;
New psychoactive substances
 (d) Continue to identify and monitor trends in the composition, production, 
prevalence and distribution of new psychoactive substances, as well as patterns of 
use and adverse consequences, and assess the risks to health and safety of individuals 
and society as a whole and the potential uses of new psychoactive substances for medi-
cal and scientific purposes, and on that basis to develop and strengthen domestic and 
national legislative, regulatory, administrative and operational responses and practices 
by domestic and national legislative, law enforcement, judiciary, social and welfare, 
educational and health authorities;
 (e) Commit to implementing timely, scientific evidence-based control or regu-
latory measures within national legislative and administrative systems to tackle and 
manage the challenge of new psychoactive substances, and consider the use of interim 
steps while substances are under review, such as provisional measures of control, or 
make public health announcements, as well as share information and expertise on 
those measures;
 (f) Share relevant information with, as appropriate, and strengthen the capacity 
of the World Health Organization, the United Nations Office on Drugs and Crime, the 
International Narcotics Control Board and other relevant international and regional 
organizations to prioritize the review of the most prevalent, persistent and harmful new 
psychoactive substances and to facilitate informed scheduling decisions by the 
Commission on Narcotic Drugs;
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 (g) Actively participate in early warning networks and promote the use of 
relevant surveillance lists and voluntary controls and the sharing of information 
through the International Narcotics Control Board, the United Nations Office on Drugs 
and Crime and the World Health Organization, within their respective mandates, and 
enhance bilateral, subregional, regional and international cooperation in the identifica-
tion and reporting of new psychoactive substances and incidents involving such 
substances and, to that end, strengthen the use of national, regional and international 
established reporting and information exchange systems, such as, where appropriate, 
the early warning advisory on new psychoactive substances and the global Synthetics 
Monitoring: Analysis, Reporting and Trends (SMART) programme of the United 
Nations Office on Drugs and Crime and Project Ion of the International Narcotics 
Control Board;
 (h) Enhance the capacity and effectiveness of national laboratories and promote 
national and regional cooperation among them, as appropriate, for the detection and 
identification of new psychoactive substances, including through the use of existing 
United Nations Office on Drugs and Crime reference standards and assistance 
activities;
 (i) Strengthen domestic information-sharing and promote information 
exchange at the regional and international levels on effective prevention and treatment 
and related legislative measures in order to support the development of effective, 
scientific evidence-based responses to the emerging challenge of new psychoactive 
substances with regard to their adverse social and health consequences;
Amphetamine-type stimulants, including methamphetamine
 (j) Support existing research, collection and scientific analysis of data 
related to amphetamine-type stimulants through the global SMART programme 
and relevant International Narcotics Control Board tools, such as Project Prism, 
and strengthen cooperation at all levels in tackling amphetamine-type stimulants, 
including methamphetamine;
 (k) Promote the use, as appropriate, of relevant existing programmes, mecha-
nisms and coordinated operations at all levels and continue the development and 
sharing of best practices and lessons learned among practitioners with regard to a 
balanced and integrated approach to the evolving threat of amphetamine-type 
stimulants;
Precursors and pre-precursors
 (l) Strengthen national, regional and international monitoring of chemicals 
used in the illicit manufacture of drugs and new psychoactive substances, with a view 
to more effectively preventing the diversion of and trafficking in those chemicals, 
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while ensuring that the legitimate trade in and use of those chemicals are not adversely 
affected, including by using national, subregional and international reporting sys-
tems and International Narcotics Control Board tools such as Project Prism, the 
Precursors Incident Communication System and Pre-Export Notification Online 
(PEN Online);
 (m) Take appropriate measures to address the diversion and illicit manufactur-
ing of and trafficking in as well as misuse of precursors under international control 
and to tackle the misuse of pre-precursors and substitute or alternative precursors for 
illicit drug manufacturing, and enhance voluntary efforts, including voluntary codes 
of conduct in cooperation with relevant industries and commerce at the national, 
regional and international levels, including through the use of relevant International 
Narcotics Control Board tools;
Non-medical use and misuse of pharmaceuticals
 (n) Enhance the sharing of information on the misuse of pharmaceuticals con-
taining narcotic drugs and psychotropic substances, and the quality and consistency 
of reported data, including through the annual report questionnaire of the United 
Nations Office on Drugs and Crime;
 (o) Develop and implement countermeasures and supportive public health, 
education and socioeconomic strategies to effectively address and counter the non-
medical use and misuse of pharmaceuticals that contain narcotic drugs and psycho-
tropic substances, while ensuring their availability for legitimate purposes, and 
promote national, subregional, regional and international cooperation to prevent their 
diversion, trafficking and abuse, including through the use of existing World Health 
Organization, United Nations Office on Drugs and Crime and International Narcotics 
Control Board projects and tools;
Use of the Internet in relation to drug-related activities
 (p) Support research, data collection, analysis of evidence and sharing of 
information and strengthen law enforcement, criminal justice and legal responses, as 
well as international cooperation, to prevent and counter drug-related criminal activ-
ities using the Internet, consistent with relevant and applicable law;
 (q) Increase the provision of technical assistance and capacity-building at all 
levels to Member States, upon request, to prevent and counter the use of technolo-
gies, including the Internet, by drug trafficking networks and transnational criminal 
organizations, to facilitate drug-related activities;
 (r) Enhance the capacity of national authorities, in particular law enforcement 
authorities, to preserve and analyse electronic evidence related to illicit activities, 
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including drug trafficking and money-laundering, and to monitor sales of illicit drugs 
using the Internet;
 (s) Encourage the use of the Guidelines for Governments on Preventing the 
Illegal Sale of Internationally Controlled Substances through the Internet,21 as 
appropriate;
 (t) Support measures on the use of the Internet for prevention purposes, 
including appropriate counselling and information provision, develop, implement 
and promote, in accordance with national legislation, prevention strategies, pro-
grammes and measures, including via social media and other social networks, aimed 
at, inter alia, protecting children and young people from the abuse of controlled sub-
stances and new psychoactive substances and from involvement in their illicit sale 
and purchase via the Internet, and enhance cooperation at all levels in that regard;
Evolving reality, trends and existing circumstances, emerging and persistent challenges 
and threats
 (u) Promote, as appropriate, the use and analysis of relevant, reliable and 
objective data generated by national and regional monitoring and evaluation to 
improve the implementation of comprehensive, integrated and balanced national 
drug control strategies, policies and programmes, in conformity with the three inter-
national drug control conventions and other relevant international instruments, and 
encourage the sharing of best practices and lessons learned, including through the 
Commission on Narcotic Drugs and other relevant regional and international organi-
zations, within their mandates, to, inter alia, better understand both their domestic 
and transnational implications;
 (v) Intensify efforts in the context of long-term and sustainable development 
programmes to address the most pressing drug-related socioeconomic factors, 
including unemployment and social marginalization, conducive to their subsequent 
exploitation by criminal organizations involved in drug-related crime;
 (w) Encourage the Commission on Narcotic Drugs, in cooperation with rele-
vant United Nations entities, within their respective mandates, to consider, as appro-
priate, reviewing existing guidelines and, where required, developing new ones on 
the various aspects of the world drug problem, with a view to enhancing the capacity 
of relevant national authorities and strengthening international and interagency 
cooperation;
 (x) Promote exchange of information to better understand the extent of 
adverse impacts, including the health, social and economic and safety impacts, of 
21 United Nations publication, Sales No. E.09.XI.6.
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drug trafficking in small quantities in order to develop, where appropriate, effective 
responses to counter microtrafficking;
 (y) Call upon the United Nations Office on Drugs and Crime, the International 
Narcotics Control Board, the World Health Organization and other United Nations 
entities with pertinent technical and operational expertise, within their mandates, to 
continue to provide, upon request, advice and assistance to States that are reviewing 
and updating their drug policies, in compliance with the international drug control 
conventions, taking into account their national priorities and needs through, among 
others, the promotion of the exchange of information and best practices on scientific 
evidence-based policies adopted by States.
Operational recommendations on strengthening international cooperation  
based on the principle of common and shared responsibility
6. We reiterate our commitment to supporting our efforts at all levels, based on com-
mon and shared responsibility, to effectively address and counter the world drug prob-
lem and to enhance international cooperation and, to that end, we recommend the 
following measures:
 (a) Strengthen specialized, targeted, effective and sustainable technical assis-
tance, including, where appropriate, adequate financial assistance, training, capacity- 
building, equipment and technological know-how, to requesting countries, including 
transit countries, through and in cooperation with the United Nations Office on Drugs 
and Crime, as well as the World Health Organization and other relevant United Nations 
entities and international and regional organizations, within their respective mandates, 
to assist Member States to effectively address the health, socioeconomic, human rights, 
justice and law enforcement aspects of the world drug problem;
 (b) Enhance North-South, South-South and triangular cooperation among 
Member States, in cooperation with the international development community and 
other key stakeholders, in order to effectively address and counter the world drug 
problem;
 (c) Strengthen, including through the Commission on Narcotic Drugs and, as 
appropriate, its subsidiary bodies, the regular exchange of information, good practices 
and lessons learned among national practitioners from different fields and at all levels 
to effectively implement an integrated and balanced approach to the world drug prob-
lem and its various aspects and consider additional measures to further facilitate mean-
ingful discussion among those practitioners;
 (d) Encourage the Commission on Narcotic Drugs to contribute to the global 
follow-up and support the thematic review of progress on the Sustainable Development 
Goals, within its mandates, bearing in mind the integrated nature of the Goals 
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as well as the interlinkages between them, and make that information available to the 
high-level political forum on sustainable development through the appropriate 
institutional framework, taking into account General Assembly resolution 70/1 of 
25 Sep tember 2015;
 (e) Encourage the Commission on Narcotic Drugs and the United Nations 
Office on Drugs and Crime to further increase cooperation and collaboration with 
all relevant United Nations entities and international financial institutions, within 
their respective mandates, when assisting Member States in designing and imple-
menting comprehensive, integrated and balanced national drug strategies, policies 
and programmes.
Operational recommendations on alternative development; regional, 
interregional and international cooperation on development-oriented  
balanced drug control policy; addressing socioeconomic issues
7. We reiterate our commitment to addressing drug-related socioeconomic issues 
related to the illicit cultivation of narcotic plants and the illicit manufacture and pro-
duction of and trafficking in drugs through the implementation of long-term, compre-
hensive and sustainable development-oriented and balanced drug control policies and 
programmes, including alternative development and, as appropriate, preventive alter-
native development programmes, which are part of sustainable crop control strategies, 
and we recommend the following measures:
Socioeconomic issues and alternative development
 (a) Target the illicit cultivation of crops used for the illicit production and 
manufacture of drugs and address related factors by implementing comprehensive 
strategies aimed at alleviating poverty and strengthening the rule of law, accountable, 
effective and inclusive institutions and public services and institutional frameworks, 
as appropriate, and by promoting sustainable development aimed at enhancing the 
welfare of the affected and vulnerable population through licit alternatives;
 (b) Encourage the promotion of inclusive economic growth and support 
initiatives that contribute to poverty eradication and the sustainability of social 
and economic development, develop measures for rural development, improving 
infrastructure and social inclusion and protection, addressing the consequences of 
illicit crop cultivation and the manufacture and production of narcotic drugs and 
psychotropic substances on the environment, with the incorporation and participa-
tion of local communities, and consider taking voluntary measures to promote prod-
ucts stemming from alternative development, including preventive alternative 
development, as appropriate, to gain access to markets, consistent with applicable 
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multilateral trade rules and with national and international law, within the framework 
of comprehensive and balanced drug control strategies;
 (c) Express concern that illicit cultivation of crops and illicit manufacture, 
distribution and trafficking remain serious challenges in addressing and countering 
the world drug problem, and recognize the need for strengthening sustainable crop 
control strategies that may include, inter alia, alternative development, eradication and 
law enforcement measures, for the purpose of preventing and reducing significantly 
and measurably the illicit cultivation of crops, and the need for intensifying joint 
efforts at the national, regional and international levels in a more comprehensive 
manner, in accordance with the principle of common and shared responsibility, 
including by means of appropriate preventive tools and measures, enhanced and better 
coordinated financial and technical assistance and action-oriented programmes, in 
order to tackle those challenges;
 (d) Consider elaborating and implementing comprehensive and sustainable 
alternative development programmes, including preventive alternative development, 
as appropriate, that support sustainable crop control strategies to prevent and signifi-
cantly, durably and measurably reduce illicit crop cultivation and other illicit drug- 
related activities, ensuring the empowerment, ownership and responsibility of affected 
local communities, including farmers and their cooperatives, by taking into account 
the vulnerabilities and specific needs of communities affected by or at risk of illicit 
cultivation, in cooperation with the United Nations Office on Drugs and Crime, the 
Food and Agriculture Organization of the United Nations, the International Labour 
Organization, the United Nations Development Programme and other relevant inter-
national organizations, bearing in mind national and regional development policies 
and action plans, with a view to contributing to the building of peaceful, inclusive and 
just societies, consistent with the Sustainable Development Goals and in compliance 
with relevant and applicable international and national law;
 (e) Strengthen subregional, regional and international cooperation to support 
comprehensive and sustainable alternative development programmes, including, as 
appropriate, preventive alternative development, as an essential part of successful pre-
vention and crop control strategies to increase the positive outcome of such pro-
grammes, especially in the areas affected by and at risk of illicit cultivation of crops 
used for the production of narcotic drugs and psychotropic substances, taking into 
account the United Nations Guiding Principles on Alternative Development;22
 (f) Strengthen regional and international cooperation to support sustainable 
alternative development programmes, including, as appropriate, preventive alterna-
tive development, in close collaboration with all relevant stakeholders at the local, 
national and international levels, and to develop and share best practices towards 
implementing the United Nations Guiding Principles on Alternative Development, 
22 Resolution 68/196, annex.
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taking into account all the lessons learned and good practices, in particular by coun-
tries with extensive expertise in alternative development, and note, inter alia, the 
Second International Conference on Alternative Development, held in Thailand from 
19 to 24 November 2015;
 (g) Promote research by States, including through cooperation with the United 
Nations Office on Drugs and Crime and other relevant United Nations entities and 
international and regional organizations, academic institutions and civil society, to bet-
ter understand factors contributing to illicit crop cultivation, taking into account local 
and regional specificities, and to improve impact assessment of alternative develop-
ment programmes, including preventive alternative development, as appropriate, with 
a view to increasing the effectiveness of these programmes, including through the use 
of relevant human development indicators, criteria related to environmental sustaina-
bility and other measurements in line with the Sustainable Development Goals;
Technical and financial cooperation for comprehensive and balanced  
development-oriented drug policies and viable economic alternatives
 (h) Consider strengthening a development perspective as part of comprehen-
sive, integrated and balanced national drug policies and programmes so as to tackle the 
related causes and consequences of illicit cultivation, manufacture, production of and 
trafficking in drugs by, inter alia, addressing risk factors affecting individuals, com-
munities and society, which may include a lack of services, infrastructure needs, drug-
related violence, exclusion, marginalization and social disintegration, in order to 
contribute to the promotion of peaceful and inclusive societies;
 (i) Urge relevant international financial institutions, United Nations entities, 
non-governmental organizations and the private sector, as appropriate, to consider 
increasing their support, including through long-term and flexible funding, for the 
implementation of comprehensive and balanced development-oriented drug control 
programmes and viable economic alternatives, in particular alternative development, 
including, as appropriate, preventive alternative development programmes, based on 
identified needs and national priorities, for areas and populations affected by or vulner-
able to the illicit cultivation of drug crops, with a view to its prevention, reduction and 
elimination, and encourage States to the extent possible to stay strongly committed to 
financing such programmes;
 (j) Encourage the development of viable economic alternatives, particularly 
for communities affected by or at risk of illicit cultivation of drug crops and other illicit 
drug-related activities in urban and rural areas, including through comprehensive alter-
native development programmes, and to this end consider development-oriented inter-
ventions, while ensuring that both men and women benefit equally from them, 
including through job opportunities, improved infrastructure and basic public services 
and, as appropriate, access and legal titles to land for farmers and local communities, 
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which will also contribute to preventing, reducing or eliminating illicit cultivation and 
other drug-related activities;
 (k) Consider the development of sustainable urban development initiatives for 
those affected by illicit drug-related activities to foster public participation in crime 
prevention, community cohesion, protection and safety and to stimulate innovation, 
entrepreneurship and employment;
 (l) Promote partnerships and innovative cooperation initiatives with the private 
sector, civil society and international financial institutions to create conditions more 
conducive to productive investments targeted at job creation in areas and among com-
munities affected by or at risk of illicit drug cultivation, production, manufacturing, 
trafficking and other illicit drug-related activities in order to prevent, reduce or elimi-
nate them, and share best practices, lessons learned, expertise and skills in this regard.
8. We express appreciation for the inclusive, transparent and open-ended preparatory 
process for the special session, led by the Commission on Narcotic Drugs with the 
support, guidance and involvement of the President of the General Assembly, and for 
all contributions to this preparatory process.
9. We resolve to take the steps necessary to implement the above-listed operational 
recommendations, in close partnership with the United Nations and other intergovern-
mental organizations and civil society, and to share with the Commission on Narcotic 
Drugs, as the policymaking body of the United Nations with prime responsibility for 
drug control matters, timely information on progress made in the implementation of 
these recommendations.
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